D. Parker Kelley, PhD
banner
sequencemyneuro.bsky.social
D. Parker Kelley, PhD
@sequencemyneuro.bsky.social
Data Science Fellow in Trauma and PTSD @ UCSF & SFVAHCS

Mitochondrial psychobiology, psychoneuroimmunology, stress, PTSD, and psychedelics

This must be the place
Reposted by D. Parker Kelley, PhD
𝗛𝗼𝘄 𝗱𝗼 𝗯𝗿𝗮𝗶𝗻 𝗮𝗿𝗲𝗮𝘀 𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝘁𝗼 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻?
"High-resolution activity maps of PFC did NOT align with cytoarchitecturally defined subregions."
Key tenet in neuroscience is that cytoarchitectonic boundaries correspond to functional ones.
NB: study in the mouse
#neuroskyence
doi.org/10.1038/s415...
January 22, 2026 at 5:35 PM
Please use full factorial designs in preclinical psychedelic research! I'm guilty of not doing so in the past, but it will be critical for understanding their MOA going forward. We need to be able to directly compare effects in pathology to those healthy organisms
January 23, 2026 at 4:29 PM
Reposted by D. Parker Kelley, PhD
Excellent interview... VERY interesting insights on stress vs mitochodrial energy balance. I wonder how much impact on stress adaptation can be gained by increasing mitochondrial resilience w keto/low carb/ Fasting and the right amount of Exercise stress (hiit, resistance trng)
December 27, 2025 at 11:13 PM
I had a fantastic discussion about our Allostatic Triage Model of Psychopathology (ATP Model) and the potential mitochondrial and metabolic effects of psychedelics with @metabolicmind.bsky.social

Thanks so much for having me on!

Check er out:

youtu.be/-e49-DwCZ9A?...
Could Stress Be The Hidden Driver of Mental Illness?
YouTube video by Metabolic Mind
youtu.be
December 10, 2025 at 8:10 PM
Warm congratulations to @carmensandi10.bsky.social for winning the Mika Salpeter award. Incredibly well-deserved as I know of few other stellar neuroscientists who have advanced the careers of women in the field
Congratulations to the 2025 SfN award & prize recipients!

Their dedication to advancing the understanding of the brain paves the way for future discoveries.

SfN looks forward to celebrating their achievements at #SfN25.

Learn about the recipients.

🔗 vist.ly/4cni8

#neurosky
November 6, 2025 at 4:53 PM
Reposted by D. Parker Kelley, PhD
Wait so midazolam is an antidepressant? Wut?
New 6-month depression RCT in n=65, serial Ketamine infusions as adjunctive care vs active placebo midazolam.

Ketamine did not outperform primary nor any of the secondary efficacy, cognitive, economic, or quality-of-life outcomes.

🧪 #psychiary #PsychSciSky

jamanetwork.com/journals/jam...
Serial Ketamine Infusions for Depression
This randomized clinical trial evaluates outcomes following adjunctive ketamine infusions vs midazolam for depression.
jamanetwork.com
October 23, 2025 at 1:32 PM
Reposted by D. Parker Kelley, PhD
Hot off the press!
🚨Publication alert! 🚨

Why does stress drive psychopathology & transdiagnostic disease?

We present the Allostatic Triage Model of Psychopathology (ATP Model), which explains stress-induced transdiagnostic disease pathogenesis through a bioenergetic lens.

www.sciencedirect.com/science/arti...
October 20, 2025 at 7:42 PM
Reposted by D. Parker Kelley, PhD
The way we feel and the psychiatric symptoms some of us end up experiencing could emerge from the way energy flows, or fails to flow smoothly, in mitochondria.

The ATP model (Allostatic Triage in Psychopathology) by Parker Kelley @sequencemyneuro.bsky.social

www.sciencedirect.com/science/arti...
October 17, 2025 at 2:42 AM
🚨Publication alert! 🚨

Why does stress drive psychopathology & transdiagnostic disease?

We present the Allostatic Triage Model of Psychopathology (ATP Model), which explains stress-induced transdiagnostic disease pathogenesis through a bioenergetic lens.

www.sciencedirect.com/science/arti...
October 20, 2025 at 3:59 PM
Reposted by D. Parker Kelley, PhD
Pα+ Psychedelic Bulletin #207

- Lykos Rebrands to Resilient

- Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision

- AbbVie-Gilgamesh Deal Viewed as Validation

- Psilocybin Rescheduling Petition Heads to HHS

- Much, much more...

psychedelicalpha.com/news/p%ce%b1...
Pα+ Psychedelic Bulletin #207: Lykos Rebrands to Resilient; Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision; AbbVie-Gilgamesh Deal Viewed as Validation - Psychedelic Alpha
Lykos Therapeutics Rebrands to Resilient Pharmaceuticals • Pharma Pushes Back on Norway’s Off-Label Ketamine Decision • AbbVie–Gilgamesh Deal Viewed as Validation for Short-Acting Psychedelics •
psychedelicalpha.com
August 28, 2025 at 5:08 PM
Reposted by D. Parker Kelley, PhD
I'm near certain sLFOs are big for psychedelics.
August 26, 2025 at 5:14 PM
Reposted by D. Parker Kelley, PhD
Just delighted to see this out in the world !! This is the first installment of SYPRES -- our living meta-analysis + open data resource focused on psychedelics. Led by the incomparable @parkersingleton.bsky.social and @bsevchik.bsky.social. Check it out + and give us your feedback!!!
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵
www.medrxiv.org/content/10.1...
August 18, 2025 at 2:37 PM
Reposted by D. Parker Kelley, PhD
It is impossible to explain to civilians how it feels to finally, FINALLY, land a clearly within-payline NIH grant score and then have it go unfunded because of all this regime bullshit.

You all have my sympathies. Unfair doesn’t even begin to describe it.
August 18, 2025 at 4:14 AM
Reposted by D. Parker Kelley, PhD
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵
www.medrxiv.org/content/10.1...
August 18, 2025 at 1:17 PM
Such a beautiful project! This is the exact sort of framework we need to advance progress going forward.
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵
www.medrxiv.org/content/10.1...
August 18, 2025 at 6:27 PM
Reposted by D. Parker Kelley, PhD
Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness, and Clinical Horizons (Part 2)

Reporting by @jasteralaina.bsky.social.

The entire Dispatch is now free to read.

psychedelicalpha.com/news/dispatc...
Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness, and Clinical Horizons (Part 2) - Psychedelic Alpha
In this second Dispatch from the inaugural Neurobiology of Psychedelics Gordon Research Conference, Dr. Alaina Jaster recaps Days 2 through 4, highlighting cutting-edge research on neuroplasticity…
psychedelicalpha.com
July 29, 2025 at 4:21 PM
Reposted by D. Parker Kelley, PhD
Since its founding in 2021 by myself and Zarmeen Zahid as Your Brain on Science, it's expanded into Psychedelic Brain Science, to encompass the larger goal of including all things psychedelic including research, policy and culture.

Now we’re expanding further to provide services! Check it out!
Psychedelic Brain Science is officially an LLC!

To celebrate we’re launching Psychedelic Brain Science Consulting where a variety of services will be offered including workshops, one-on-one coaching, general consulting, independent analysis, and more!

For details visit our website!
Psychedelics | Your Brain On Science
Your Brain on Science is a psychedelic science communication platform dedicated to making psychedelic science accessible, understandable, and relatable for all through blog posts and podcast episodes.
www.psychedelicbrainscience.com
July 30, 2025 at 3:29 PM
Reposted by D. Parker Kelley, PhD
Had a blast at the first ever #GRCPsychedelics - thanks so much to Chairs @alexkwan.bsky.social @vyazovskiy.bsky.social & Vice Chairs @melissaherman.bsky.social @viditavaidya.bsky.social for bringing our community together 🫶

Per usual, I took no pics - but luckily Missy had it covered for me 😂
July 18, 2025 at 11:25 PM
Reposted by D. Parker Kelley, PhD
Attending the first psychedelic GRC organized by @alexkwan.bsky.social & @vyazovskiy.bsky.social was surreal. The internationally representative panels ensure we are collectively/efficiently advancing our understanding of psychedelics. Special thanks to
@mayoonthebrain.bsky.social for bringing me ❤️
July 18, 2025 at 6:09 PM
Reposted by D. Parker Kelley, PhD
July 18, 2025 at 12:29 AM
Reposted by D. Parker Kelley, PhD
July 17, 2025 at 11:22 PM
Obviously the mitochondria is the best organelle.

1 can leave cell, but stays
2 own genome
3 regulates nuclear gene expression
4 can kill whole cell
5 makes energy, distributes it to orchestrate cellular processes
6 controls whole organisms behavior
7 makes (sex, growth, stress, etc) steroids
July 17, 2025 at 7:46 PM